Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-27 Option Award | 2023-06-29 4:16 pm | N/A 2033-06-26 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 7:13 pm | N/A 2033-06-15 | Senti Biosciences Inc. | SNTI | Collins James J. Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2023-05-17 Disposition | 2023-05-18 4:05 pm | N/A N/A | Orion Biotech Opportunities Corp. | ORIA | Collins James J. Director | 40,000 | $0 | 0 (Direct) | View |
| 2022-07-13 Option Award | 2022-07-15 6:00 pm | N/A 2032-07-12 | Senti Biosciences Inc. | SNTI | Collins James J. Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-06-27 Option Award | 2022-06-29 5:00 pm | N/A 2032-06-26 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 19,000 | $0 | 19,000 (Direct) | View |
Ownership | 2022-06-15 6:01 pm | N/A N/A | Senti Biosciences Inc. | SNTI | Collins James J. Director | 0 | $0 | 194,858 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 5:11 pm | N/A 2031-06-08 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 15,000 | $0 | 15,000 (Direct) | View |
Ownership | 2021-05-12 8:15 pm | N/A N/A | Orion Biotech Opportunities Corp. | ORIA | Collins James J. Director | 0 | $0 | 40,000 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 4:15 pm | N/A 2030-06-10 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 9,285 | $0 | 9,285 (Direct) | View |
| 2019-07-18 Option Award | 2019-07-18 5:28 pm | N/A 2029-07-17 | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 5,714 | $0 | 5,714 (Direct) | View |
Ownership | 2019-07-17 7:36 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Collins James J. Director | 0 | $0 | 30,713 (Direct) | View |